scholarly article | Q13442814 |
P50 | author | Stephen J. Wigmore | Q48085030 |
Luca Antonio Aldrighetti | Q88601450 | ||
P2093 | author name string | O James Garden | |
Rowan W Parks | |||
Martin Bodingbauer | |||
Carlo Pulitanò | |||
Gianfranco Ferla | |||
Federico Castillo | |||
P2860 | cites work | Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents | Q31111685 |
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 | ||
Trends in long-term survival following liver resection for hepatic colorectal metastases | Q34523502 | ||
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival | Q34551117 | ||
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases | Q34557044 | ||
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors | Q34680919 | ||
Actual 10-year survival after resection of colorectal liver metastases defines cure. | Q34699863 | ||
Expanding criteria for resectability of colorectal liver metastases | Q37075581 | ||
Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases | Q41186718 | ||
Guidelines for resection of colorectal cancer liver metastases. | Q42150472 | ||
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history | Q43990247 | ||
Resection of hepatic metastases from colorectal cancer | Q44454061 | ||
R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? | Q45674652 | ||
Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases | Q45895324 | ||
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma | Q46816802 | ||
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases | Q47287366 | ||
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases | Q49186620 | ||
Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin | Q73649108 | ||
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer | Q73954807 | ||
Factors influencing survival of patients undergoing hepatectomy for colorectal metastases | Q77319884 | ||
Long-term characteristics of 5-year survivors after liver resection for colorectal metastases | Q79604161 | ||
Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer | Q79917337 | ||
Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making | Q80554863 | ||
Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity | Q81234867 | ||
P433 | issue | 4 | |
P304 | page(s) | 244-249 | |
P577 | publication date | 2010-05-01 | |
P1433 | published in | Hepato Pancreato Biliary | Q15756742 |
P1476 | title | What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up | |
P478 | volume | 12 |
Q38091102 | A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases |
Q37933143 | A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases |
Q38092734 | A systematic review of repeat hepatectomy for recurrent colorectal liver metastases. |
Q36953786 | A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases |
Q49887458 | Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? |
Q38852221 | An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence |
Q37623502 | Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases |
Q38696070 | Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection |
Q26778009 | Colorectal cancer: Metastases to a single organ |
Q43798315 | Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection |
Q50077917 | Comments to "Long-Term Survival Benefit and Potential for Cure After R1 Resection for Colorectal Liver Metastases". |
Q51014362 | Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases. |
Q35653302 | Current state of surgical treatment of liver metastases from colorectal cancer |
Q26864128 | Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases |
Q97074205 | Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer |
Q42006606 | Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial |
Q93000188 | Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer |
Q40513991 | Impact of totally laparoscopic combined management of colorectal cancer with synchronous hepatic metastases on severity of complications: a propensity-score-based analysis |
Q38225773 | Laparoscopic approach to a planned two-stage hepatectomy for bilobar colorectal liver metastases. |
Q87621611 | Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up |
Q43661052 | Parenchyma-preserving hepatic resection for colorectal liver metastases |
Q36915703 | Patient perceptions regarding the likelihood of cure after surgical resection of lung and colorectal cancer. |
Q40261480 | Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease. |
Q37876340 | Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature |
Q26774687 | Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection |
Q58695102 | Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases |
Q40118086 | Radiofrequency ablation or resection for small colorectal liver metastases - a plea for caution |
Q37482898 | Resection margin influences the outcome of patients with bilobar colorectal liver metastases |
Q36501711 | Role of a liver-first approach for synchronous colorectal liver metastases |
Q39063517 | Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy. |
Q37977308 | Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. |
Q49580510 | The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer |
Q47741359 | Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment |
Q37008553 | Use of the word "cure" in oncology |
Q34576835 | Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver? |
Q39018756 | miR-30b regulates migration and invasion of human colorectal cancer via SIX1. |
Search more.